These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 24177324

  • 21. Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of RAGE with its ligands.
    Rao NV, Argyle B, Xu X, Reynolds PR, Walenga JM, Prechel M, Prestwich GD, MacArthur RB, Walters BB, Hoidal JR, Kennedy TP.
    Am J Physiol Cell Physiol; 2010 Jul; 299(1):C97-110. PubMed ID: 20375277
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparison of hemorrhagic effect of heparin and human activated protein C with use of Thrombostat 4000.
    Katsuura Y, Tanabe H, Kiyoki M, Funatsu A.
    Haemostasis; 1996 Jul; 26(4):203-9. PubMed ID: 8872131
    [Abstract] [Full Text] [Related]

  • 25. Antithrombin-independent thrombin inhibitors, but not direct factor Xa inhibitors, enhance thrombin generation in plasma through inhibition of thrombin-thrombomodulin-protein C system.
    Furugohri T, Sugiyama N, Morishima Y, Shibano T.
    Thromb Haemost; 2011 Dec; 106(6):1076-83. PubMed ID: 22012070
    [Abstract] [Full Text] [Related]

  • 26. Quantitative analysis of thrombomodulin-mediated conversion of protein C to APC: translation from in vitro to in vivo.
    Carnemolla R, Patel KR, Zaitsev S, Cines DB, Esmon CT, Muzykantov VR.
    J Immunol Methods; 2012 Oct 31; 384(1-2):21-4. PubMed ID: 22750541
    [Abstract] [Full Text] [Related]

  • 27. Characteristic effects of activated human protein C on tissue thromboplastin-induced disseminated intravascular coagulation in rabbits.
    Katsuura Y, Aoki K, Tanabe H, Kiyoki M, Funatsu A.
    Thromb Res; 1994 Nov 15; 76(4):353-62. PubMed ID: 7871494
    [Abstract] [Full Text] [Related]

  • 28. The platelet proaggregating and potentiating effects of unfractionated heparin, low molecular weight heparin and heparinoid in intensive care patients and healthy controls.
    Burgess JK, Chong BH.
    Eur J Haematol; 1997 Apr 15; 58(4):279-85. PubMed ID: 9186540
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A novel heparin-dependent inhibitor of activated protein C that potentiates consumptive coagulopathy in Russell's viper envenomation.
    Cheng AC, Wu HL, Shi GY, Tsai IH.
    J Biol Chem; 2012 May 04; 287(19):15739-48. PubMed ID: 22416129
    [Abstract] [Full Text] [Related]

  • 31. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential.
    Chan AK, Berry LR, Monagle PT, Andrew M.
    Thromb Haemost; 2002 Apr 04; 87(4):606-13. PubMed ID: 12008942
    [Abstract] [Full Text] [Related]

  • 32. Effect of rivaroxaban, in contrast to heparin, is similar in neonatal and adult plasma.
    Novak M, Schlagenhauf A, Bernhard H, Schweintzger S, Leschnik B, Muntean W.
    Blood Coagul Fibrinolysis; 2011 Oct 04; 22(7):588-92. PubMed ID: 21799400
    [Abstract] [Full Text] [Related]

  • 33. Effect of activated human protein C on experimental venous thrombosis induced by stasis with operative invasion in mice.
    Aoki Y, Fukumoto Y, Inoue K, Katsuura Y, Komoriya K, Miyamoto S.
    Arzneimittelforschung; 2000 Aug 04; 50(8):695-9. PubMed ID: 10994152
    [Abstract] [Full Text] [Related]

  • 34. [On the fibrinolytic effect of heparin and heparinoids].
    Naegeli T, Matis P.
    Zentralbl Chir; 1965 Jun 05; 90(23):881-3. PubMed ID: 4157844
    [No Abstract] [Full Text] [Related]

  • 35. Effect of activated human protein C on disseminated intravascular coagulation induced by lipopolysaccharide in rats.
    Aoki Y, Ota M, Katsuura Y, Komoriya K, Nakagaki T.
    Arzneimittelforschung; 2000 Sep 05; 50(9):809-15. PubMed ID: 11050697
    [Abstract] [Full Text] [Related]

  • 36. The effect of the anticoagulation regimen on endothelial-related coagulation in cardiac surgery patients.
    Boldt J, Schindler E, Welters I, Wittstock M, Stertmann WA, Hempelmann G.
    Anaesthesia; 1995 Nov 05; 50(11):954-60. PubMed ID: 8678251
    [Abstract] [Full Text] [Related]

  • 37. Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.
    Gatt A, van Veen JJ, Woolley AM, Kitchen S, Cooper P, Makris M.
    Thromb Haemost; 2008 Aug 05; 100(2):350-5. PubMed ID: 18690358
    [Abstract] [Full Text] [Related]

  • 38. Heparin-Functionalized Adsorbents Eliminate Central Effectors of Immunothrombosis, including Platelet Factor 4, High-Mobility Group Box 1 Protein and Histones.
    Ebeyer-Masotta M, Eichhorn T, Weiss R, Semak V, Lauková L, Fischer MB, Weber V.
    Int J Mol Sci; 2022 Feb 05; 23(3):. PubMed ID: 35163743
    [Abstract] [Full Text] [Related]

  • 39. In vitro effects of detergent sclerosants on antithrombotic mechanisms.
    Parsi K, Exner T, Low J, Ma DD, Joseph JE.
    Eur J Vasc Endovasc Surg; 2009 Aug 05; 38(2):220-8. PubMed ID: 19442540
    [Abstract] [Full Text] [Related]

  • 40. Circulating Histones in Sepsis: Potential Outcome Predictors and Therapeutic Targets.
    Li Y, Wan D, Luo X, Song T, Wang Y, Yu Q, Jiang L, Liao R, Zhao W, Su B.
    Front Immunol; 2021 Aug 05; 12():650184. PubMed ID: 33868288
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.